Role of ethnicity in chlorzoxazone hydroxylation and CYP2E1 activity

被引：0
|
作者：
Alvarado, LM [1 ]
Fuentes, MG [1 ]
Brown, K [1 ]
Dreisbach, AW [1 ]
George, WJ [1 ]
Lertora, JJ [1 ]
机构：
[1] TULANE UNIV,SCH MED,DEPT MED & PHARMACOL,NEW ORLEANS,LA 70112
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1996年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：PI32 / PI32
页数：1
相关论文
共 50 条
  • [1] Chlorzoxazone hydroxylation in male and female subjects as an index of CYP2E1 activity.
    Alvarado, L
    Fuentes, MG
    Brown, K
    Dreisbach, AW
    George, WJ
    Lertora, JJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A60 - A60
  • [2] Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation
    Burckart, GJ
    Frye, RF
    Kelly, P
    Branch, RA
    Jain, A
    Fung, JJ
    Starzl, TE
    Venkataramanan, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (03) : 296 - 302
  • [3] RELATIONSHIP IN HEALTHY-SUBJECTS BETWEEN CYP2E1 GENETIC POLYMORPHISMS AND THE 6-HYDROXYLATION OF CHLORZOXAZONE - A PUTATIVE MEASURE OF CYP2E1 ACTIVITY
    KIM, RB
    OSHEA, D
    WILKINSON, GR
    PHARMACOGENETICS, 1994, 4 (03): : 162 - 165
  • [4] EFFECT OF FASTING AND OBESITY IN HUMANS ON THE 6-HYDROXYLATION OF CHLORZOXAZONE - A PUTATIVE PROBE OF CYP2E1 ACTIVITY
    OSHEA, D
    DAVIS, SN
    KIM, RB
    WILKINSON, GR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) : 359 - 367
  • [5] Reliability of chlorzoxazone as an in vivo probe of CYP2E1 activity in humans.
    Ernstgård, L
    Rannug, A
    Warholm, M
    Johanson, G
    TOXICOLOGICAL SCIENCES, 2003, 72 : 319 - 319
  • [6] Chlorzoxazone as a single sample probe of hepatis CYP2E1 activity in humans
    Bachmann, K
    Sarver, JG
    PHARMACOLOGY, 1996, 52 (03) : 169 - 177
  • [7] Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers
    Bedada, Satish Kumar
    Boga, Praveen Kumar
    XENOBIOTICA, 2017, 47 (12) : 1035 - 1041
  • [8] Watercress inhibits human CYP2E1 activin in vivo as measured by chlorzoxazone 6-hydroxylation.
    Kim, RB
    Wilkinson, GR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII46 - PII46
  • [9] Resveratrol Pretreatment Affects CYP2E1 Activity of Chlorzoxazone in Healthy Human Volunteers
    Bedada, Satish Kumar
    Neerati, Prasad
    PHYTOTHERAPY RESEARCH, 2016, 30 (03) : 463 - 468
  • [10] Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans
    Lucas, D
    Ferrara, R
    Gonzalez, E
    Bodenez, P
    Albores, A
    Manno, M
    Berthou, F
    PHARMACOGENETICS, 1999, 9 (03): : 377 - 388
12345